Health innovations in patient decision support: Bridging the gaps and challenges by Ng, Chirk Jenn et al.
 Australasian Medical Journal [AMJ 2013, 6, 2, 95-99] 
 
 
95 
 
 
 
 
 
 
REVIEW 
  
Please cite this paper as: Ng CJ, Lee YK, Lee PY, Khatijah LA. 
Health innovations in patient decision support: Bridging the 
gaps and challenges. AMJ 2013, 6, 2, 95-99. 
http//dx.doi.org/10.4066/AMJ.2013.1655. 
 
 
 
 
 
 
 
  
 
Abstract 
 
Patient decision aids (PDAs) help to support patients in 
making an informed and value-based decision. Despite 
advancement in decision support technologies over the past 
30 years, most PDAs are still inaccessible and few address 
individual needs. Health innovation may provide a solution to 
bridge these gaps. Information and computer technology 
provide a platform to incorporate individual profiles and 
needs into PDAs, making the decision support more 
personalised. Health innovation may enhance accessibility by 
using mobile, tablet and Internet technologies; make risk 
communication more interactive; and identify patient values 
more effectively. In addition, using databases to capture 
patient data and the usage of PDAs can help: developers to 
improve PDAs’ design; clinicians to facilitate the decision-
making process more effectively; and policy makers to make 
shared decision making more feasible and cost-effective. 
Health innovation may hold the key to advancing PDAs by 
creating a more personalised and effective decision support 
tool for patients making healthcare decisions. 
Key Words 
Patient decision aids; shared decision making; health 
innovation 
 
Introduction: 
Expanding research evidence has made the practice of 
evidence-based medicine more challenging.
1
 When making a  
 
 
 
 
 
 
 
 
 
 
healthcare decision, patients, often guided by their 
clinicians, need to weigh the pros and cons of each option 
while considering their personal values.
1
 This is a 
challenging task because patients need to acquire and 
understand the health information provided while 
clinicians need to be updated regularly with accurate 
information and communicate it to the patients in an 
unbiased manner. The decision-making process becomes 
even more complex when there is no single best option or 
when decisions are based on a patient’s own preference 
(e.g., early breast or prostate cancer, insulin therapy).
2-4
 
 
Over the past three decades, clinicians and researchers 
have started developing tools and interventions to 
improve patient decision quality and outcomes. Currently, 
the main decision support interventions include: (1) 
training clinicians to support patients in decision making; 
(2) decision coaching; and (3) patient decision aids 
(PDAs).
5,6
 Among these, PDAs are the most well studied 
and found to be effective in: improving patient decision 
quality such as increasing knowledge and accurate risk 
perception; reducing decisional conflict; increasing 
participation in decision making; and helping patients to 
make a choice that is consistent with their own values.
7
 
 
Patient decision aids: Historical perspective 
PDAs are evidence-based tools designed to help patients 
participate in making specific and deliberated choices 
among healthcare options.
7,8
 A PDA contains information 
on the healthcare options available as well as the risks 
and benefits of each option. It also helps to clarify patient 
values (what is important to the patient) and guide them 
systematically through the decision making process. The 
International Patient Decision Aids Standards (IPDAS) 
identify key components and standards of a high quality 
patient decision aid.
8
 
 
In this review, we tracked the development of PDAs by 
extracting information from the 86 studies included in the 
recently updated Cochrane Review on the effectiveness of 
decision aids.
7
 We limited the PDAs review to those 
published in the Cochrane Review because they have 
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been subjected to rigorous appraisal and are deemed to be of 
high quality.  
 
Over the span of 26 years (1983-2009), PDAs have evolved 
from simple decision support tools to more complex ones. The 
format of the PDAs expanded from using pamphlets (1983), 
interactive multimedia (1995), script of option outcomes 
(1996), education and counselling on option outcomes (1997), 
audiotapes (1997), videos (1998), booklets (2000), CD-ROM 
(2001), computer programmes (2002), decision boards (2003), 
to internet (2007). Despite the advancements in the 
development of PDAs over the years, the challenge remains 
how to develop a decision support tool that suits individual 
needs. When choosing a PDA, it is important to consider the 
patient’s age, gender, ethnicity, language, and cultural and 
education background.
9
 Few PDAs take into consideration 
these factors and they are limited by the format of the PDA. 
There are, therefore, opportunities for health innovations to 
provide decision support according to individual clinical profile 
and needs. 
 
Potential areas for health innovation in patient 
decision support 
Use of information and computer technology (ICT)  
There is an increasing number of web-based PDAs developed 
worldwide.
7,10
 Web-based PDAs are easier and cheaper to 
update compared to other types of PDAs such as booklets or 
videos. However, the Internet may not be readily available in 
some parts of the world and not all users have access to 
computers. Mobile telephone technology is a possible 
solution to this problem as it is widely used even in 
underdeveloped or developing countries.
11
 Mobile 
applications can be downloaded with minimal cost or for free 
and are, therefore, more accessible to target users.  
 
PDAs are tools meant to supplement, not replace, clinical 
consultations. Computers, mobile telephone, and tablets are 
readily available tools that can be used by both patients and 
clinicians to discuss the options and decisions within or 
outside the consultations. There are concerns that this may 
marginalise older people who may not be IT-savvy. However, 
there is increasing evidence to suggest that older people are 
not averse to technology;
12
 the use of the Internet among the 
elderly has increased in recent years and older patients who 
are making decisions about their chronic illnesses may benefit 
from PDA innovations using the latest technology.  
 
In addition, the use of ICT can make patient decision making 
more interactive. The use of animation, videos, audio-visual 
aids, and personalised options allow patients, especially those 
with a lower education level, to be more engaged in the 
decision-making process. The amount of information 
presented to the patient can be presented in stages or 
controlled by users to avoid information overload. The 
use of navigation function allows users to select 
information that is relevant to them. Moreover, 
developers can create mandatory fields to ensure that 
users read and understand key information provided in 
the PDA. 
 
Risk communication  
One important function of a PDA is to present risks and 
benefits of each healthcare option to patients in an 
unbiased manner. Currently, PDA developers use 
numbers, texts, and pictures (e.g. ‘smileys’) to 
communicate risks to patients.
8
 However, recent studies 
have found that users may not be interested in the figures 
presented, probably because they have difficulty 
understanding the information or they feel that the risks 
and benefits may not be applicable to them.
13
 Using ICT, 
patients’ clinical information can be incorporated into 
PDAs and used to assess their clinical risks. This will more 
accurately predict the risks and benefits of choosing each 
of the treatment options. Using interactive audio-visual 
presentation, complex information, including statistics, 
could be made simpler and clearer to users, particularly 
for those with a lower education level.
14
 
 
Value clarification 
Value clarification is a unique and important feature of a 
PDA and this differentiates itself from health education 
materials.
15
 Value clarification exercises help patients to 
express what is important to them when making a 
decision. Clinicians should be aware of patients’ concerns 
and priorities in order to guide them to make a decision 
that aligns with their preference. Value-based decisions 
are more likely to be followed through.
8
 So far, value 
clarification exercises in PDAs have used a ‘weighing scale’ 
approach where patients weigh the pros and cons of the 
treatment options by indicating their level of 
preference.
16
 These exercises become more complex 
when there are more than two options to choose from 
and/or there are multiple risks and benefits in each 
option. The use of ICT may help to simplify the value 
clarification process by allowing patients to select their 
preferred options; identifying the risks and benefits that 
are important to them; and visualising the significance of 
these options and their attributes.  
 
For patients to make an informed decision, they should be 
able to forecast what they are likely to experience if they 
were to choose a particular option.
17
 To achieve this, 
PDAs can use videos or animation to present personal 
stories about the pros and cons of each treatment option. 
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By imagining ‘what life would be like’ living with the choice, 
patients are more likely to adhere to the treatment and less 
likely to regret their decision. 
 
Language and culture 
In a multilingual, multicultural society, it is crucial to develop a 
decision support tool in different languages and tailor it 
according to different cultural contexts. Previous studies have 
found that patients and clinicians tend to perceive ‘imported’ 
PDAs as irrelevant to their needs.
18
  Therefore, PDAs that are 
sensitive to patients’ preferred language and culture are more 
acceptable and, hence, more likely to be used by patients and 
their clinicians. This can be achieved more easily by using 
health innovations, for example, by presenting the 
information in different languages and using culturally 
sensitive texts and visual aids.  
 
Database on decision-making process 
While using a patient decision aid, individual patient data can 
be captured using ICT. These data are important in helping 
clinicians and researchers to understand how patients make 
decisions. For instance, we can identify the pattern in decision 
making by documenting: the web pages that patients browse; 
the time users spend on each page; which options they prefer; 
what their concerns and priorities are; their readiness to 
making a decision; and their preferred choice. These data 
could then be summarised and reviewed by: (1) patients to 
facilitate discussion with their clinician or family about their 
decision; (2) clinicians to better understand and address 
patients’ concerns and, hence, make the consultation more 
effective; (3) researchers to improve the design of the PDA; 
and (4) policy makers to devise cost-effective strategies to 
promote shared decision making. 
 
PDA clearinghouse 
Currently, the most comprehensive PDA inventory that 
collects and classifies PDAs is the Decision Aid Library 
Inventory (DALI) (Canada) which archives more than 300 
PDAs.
19
 Other independent organisations, such as Healthwise 
(USA),
20
 Health Dialog (USA),
21
 Foundation for Informed 
Decision Making (USA)
22
 and National Health Service (UK),
23
 
also produce and disseminate PDAs developed by its own 
institution. However, the registration of PDAs are entirely 
voluntary or institution-based and there is no systematic 
approach to capture PDAs that are available or under 
development worldwide. As a result, there are significant 
overlaps in the development of PDAs. For instance, there are 
currently 10 PDAs on prostate cancer treatment registered 
with DALI, some from the same country; this has resulted in 
duplication of work and wastage of time and resources. 
Therefore, a web-based PDA clearinghouse that coordinates 
the collection, appraisal and dissemination of PDAs would 
help to make PDAs more accessible to developers, 
clinicians and, more importantly, patients.  
 
Opportunities and challenges in PDA health 
innovations 
Despite the significant advancement in decision support 
technologies in the past 30 years, there are still significant 
gaps in finding effective ways to support individual 
patients in making informed healthcare decisions. Health 
innovation may form part of the solutions to bridge these 
gaps. Potentially, health innovations using ICT can save 
costs in terms of cutting down printing and reprinting as 
regular updates are necessary with rapidly emerging 
clinical evidence. Current PDAs lack flexibility in terms of 
personalisation of data, interactiveness and accessibility. 
The use of ICT can overcome these limitations by 
capturing individual clinical data, transforming them into 
interactive risk communication tools, and offering 
language and format that patients prefer.  
 
However, the development and implementation of health 
innovations have their own limitations. Firstly, it requires 
ICT experts and infrastructure, which may not be readily 
available or affordable in some countries. Secondly, users, 
including patients and clinicians, need training on how to 
use the PDA, particularly if it involves complex navigation 
through the web site and if users are not IT-savvy. Thirdly, 
ICT has inherent security issues and this requires careful 
planning as confidential patient data are collected, stored, 
and used by different stakeholders. Fourthly, as with all 
innovations, the stakeholders may resist the diffusion of 
new technologies such as decision support tools. Finally, 
health innovation is a means to an end: patient decision 
aids should not replace face-to-face interaction with a 
clinician, particularly when making complex decisions. 
Guidance by the clinicians, supplemented by a patient 
decision aid, will help patients to make a more informed 
and value-based decision. 
 
Conclusion 
Supporting patients in decision making is an important 
part of patient-centred care. This can be achieved by 
using decision support tools to assist clinicians in their 
busy practice. Using health innovations, rapidly changing 
evidence can be incorporated into the decision support 
tool; patients can learn about their illness and treatment 
options more interactively; and they can express their 
personal values and clinical risks to the clinicians more 
directly. Individual data can then be collated using ICT to 
improve design of PDA and understand the patient 
decision-making process. This may be the key to 
developing more personalised and cost-effective decision 
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support tools that could improve patients’ decision-making 
experience and outcome. 
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